Watchlist Price Alert

MiNK Therapeutics Inc. (INKT)

NASDAQ: INKT · Real-Time Price · USD

7.60

0.20 (2.70%)

At close: May 02, 2025, 3:48 PM

7.96

4.74%

After-hours: May 02, 2025, 04:05 PM EDT

MiNK Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-10.78M	-22.46M	-27.99M	-30.21M	-16.24M	-23.8M
Depreciation & Amortization	215.44K	204.62K	121.75K	77.96K	55.06K	36.82K
Stock-Based Compensation	1.81M	3.86M	3.03M	1.74M	87.83K	219.57K
Other Working Capital	1.64M	4.81M	6.11M	3.89M	-932.79K	3.23M
Other Non-Cash Items	-1.26M	-266.78K	-2.79M	12.18M	8.08M	4.49M
Deferred Income Tax	n/a	n/a	n/a	-355.51K	n/a	n/a
Change in Working Capital	459.73K	2.9M	8.77M	3.74M	-324.93K	4.12M
Operating Cash Flow	-9.56M	-15.76M	-18.87M	-12.83M	-8.34M	-14.94M
Capital Expenditures	n/a	-73.56K	-250.05K	-248.98K	-95.21K	-426.47K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-250.05M	-248.98M	n/a	n/a
Investing Cash Flow	n/a	-73.56K	-250.05K	-248.98K	-95.21K	-426.47K
Debt Repayment	5M	n/a	n/a	9.46M	11.11M	11.44M
Common Stock Repurchased	n/a	-477.64K	-157.19K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	19.99K	70.47K	1.59K	150.00	n/a	n/a
Financial Cash Flow	10.82M	-407.17K	-155.6K	49.26M	11.11M	11.44M
Net Cash Flow	1.21M	-16.27M	-19.25M	36.2M	2.39M	-4.06M
Free Cash Flow	-9.56M	-15.84M	-19.12M	-13.08M	-8.43M	-15.37M